Drug Type AAV based gene therapy |
Synonyms- |
Target- |
Mechanism Gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Atsena Therapeutics, Inc.Startup |
Active Organization Atsena Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Usher Syndrome, Type Ib | Preclinical | US | Atsena Therapeutics, Inc.Startup | - |